Prenetics Announces Participation in December Investor Conferences

Rhea-AI Summary

Prenetics Global (NASDAQ: PRE) has announced its participation in two upcoming investor conferences in December 2024. The company will attend the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, where CEO Danny Yeung will present on December 10 at 10:00am ET, followed by one-on-one meetings with CFO Stephen Lo and Prenetics Americas President David Vanderveen on December 11.

Additionally, David Vanderveen will represent the company at the 13th Annual ROTH Deer Valley Event in Park City, UT from December 11-13, conducting one-on-one investor meetings throughout the conference.

CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the Prenetics management team will participate in two upcoming investor conferences.

iAccess Alpha Virtual Best Ideas Winter Conference 2024

Date: December 10-11, 2024

Location: Virtual

Presentation: December 10, 2024 at 10:00am ET

Webcast: https://www.webcaster4.com/Webcast/Page/3074/51539

Danny Yeung, Chief Executive Officer, will deliver a presentation on December 10, 2024, and will be joined by Stephen Lo, Chief Financial Officer, and David Vanderveen, President of Prenetics Americas, for one-on-one investor meetings to be held on December 11, 2024.

13th Annual ROTH Deer Valley Event

Date: December 11-13, 2024

Location: Park City, UT

David Vanderveen, President of Prenetics Americas, will be hosting one-on-one investor meetings throughout the conference.

Mr. Vanderveen has had a successful 30-year track record in beverage, nutrition, and technology, leading disruptive change at both Nirvana Water Sciences and XS Worldwide as prior CEO.

For more information or to schedule a meeting with management, please contact the Company’s investor relations at PRE@mzgroup.us.

About Prenetics

Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million venture focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. To learn more about Prenetics, please visit www.prenetics.com.

Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us

Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
angela.hm.cheung@prenetics.com

FAQ

When is Prenetics (PRE) presenting at the iAccess Alpha Virtual Conference 2024?

Prenetics (PRE) CEO Danny Yeung will present at the iAccess Alpha Virtual Conference on December 10, 2024, at 10:00am ET.

Which investor conferences is Prenetics (PRE) attending in December 2024?

Prenetics (PRE) is attending the iAccess Alpha Virtual Best Ideas Winter Conference (Dec 10-11) and the 13th Annual ROTH Deer Valley Event (Dec 11-13).

Who will represent Prenetics (PRE) at the ROTH Deer Valley Event 2024?

David Vanderveen, President of Prenetics Americas, will represent Prenetics (PRE) at the ROTH Deer Valley Event, hosting one-on-one investor meetings.